The economic consequences of diabetes and cardiovascular disease in the United States
- First Online:
- Cite this article as:
- Ariza, M.A., Vimalananda, V.G. & Rosenzweig, J.L. Rev Endocr Metab Disord (2010) 11: 1. doi:10.1007/s11154-010-9128-2
- 398 Downloads
Diabetes-related care and complications constitute a significant proportion of the United States’ (US) health care expenditure. Of these complications, cardiovascular disease (CVD) is a major component. Higher morbidity and mortality rates translate to higher costs of care in patients with diabetes compared to those who do not have the disease. Minorities bear a disproportionate burden of diabetes and CVD. We review this disparity and examine potential etiologies for it in Hispanics and African-Americans, the two largest minority groups in the US. We examine strategies in these populations that may improve outcomes in diabetes and CVD, potentially decreasing health care costs.